Preferred Label : Paclitaxel/Pertuzumab/Trastuzumab Regimen;
NCIt synonyms : Pertuzumab-Trastuzumab-Paclitaxel; Pertuzumab-Trastuzumab-Paclitaxel Regimen; THP (Taxol) Regimen; Pertuzumab/Trastuzumab/Paclitaxel Regimen; Taxol/Herceptin/Pertuzumab; Pertuzumab Trastuzumab Paclitaxel;
NCIt related terms : THP (Paclitaxel); THP (Paclitaxel) (trastuzumab-zerc); THP (Paclitaxel) (trastuzumab-qyyp); THP (Paclitaxel) (trastuzumab-anns); THP (Paclitaxel) (trastuzumab-pkrb); THP (Paclitaxel) (trastuzumab-herw); THP (Paclitaxel) (trastuzumab-dkst); THP (Paclitaxel) (trastuzumab-dttb);
NCIt definition : A regimen consisting of pertuzumab, trastuzumab and paclitaxel, used as a treatment
for recurrent and metastatic HER-2/neu-positive breast cancer.;
NCIt note : Source: NCCN Guidelines 2017;
NCI Metathesaurus CUI : CL524992;
Codes from synonyms : 75392; 128974; 128877; 129362; 129265; 129168; 129459; 129071;
Origin ID : C138045;
UMLS CUI : C4527351;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
